qhpv

Females were at higher risk of mortality compared to males in 1st Covid wave, claims study-

NTAGI to review trial data on Serum Institute’s qHPV vaccine against cervical cancer-

admin

By PTI NEW DELHI: The government advisory panel NTAGI is likely to review on June 28 trial data on India’s ...

Government panel recommends market authorisation for SII's qHPV vaccine against cervical cancer-

Government panel recommends market authorisation for SII’s qHPV vaccine against cervical cancer-

admin

By PTI NEW DELHI: An expert panel of India’s central drug authority on Wednesday recommended granting of market authorisation to ...